Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben‐David, Todd R. Golub, Craig A. Strathdee et al.|Nature|2018Cited by 943
Discovering the anticancer potential of non-oncology drugs by systematic viability profilingSteven M. Corsello, Todd R. Golub, Rohith T. Nagari et al.|Nature Cancer|2020Cited by 880
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibitionYael Cohen‐Sharir, Uri Ben‐David, James M. McFarland et al.|Nature|2021Cited by 302